Parkinson's disease dementia

There are 52 papers on Parkinson's disease dementia in aging research: 1 trial and 40 observational studies in people, 9 reviews. The newest story, Oct 4, 2026: “Probable REM sleep disorder links to Lewy body dementia”.

Disease

52 papers study it26 more mention it15 findings

3 new papers in 30 daysSee all 78 papers on Parkinson's disease dementia

“Overall AAMR rose significantly from 1999 to 2001 (APC = 25.95; 95% CI 12.06–37.38), plateaued until 2018, and increased again through 2020 (APC = 11.21; 95% CI 2.49–15.71; AAPC = 3.04; 95% CI 2.33–3.86).”
Divergent mortality associated with Parkinson’s disease dementia in the United States from 1999 to 2020Archives of Gerontology and Geriatrics Plus2026doi:10.1016/j.aggp.2026.100272
  • Human trial1
  • Humans40
  • In silico1

Effects

2

Mortality

upin humans1

1 study
  1. Parkinson's disease dementia is linked with higher mortality in humans (AAPC = 3.04, 95% CI 2.33–3.86).

    Humans1999 to 2020

11C-BU99008 volume of distribution

no changein humans1

1 study
  1. Parkinson's disease dementia was not clearly linked with 11C-BU99008 volume of distribution in humans (Parkinson's disease dementia vs age-matched healthy controls).

    HumansParkinson's disease dementia vs age-matched healthy controlsbrain

More on 11C-BU99008 volume of distribution

Upstream

1

Sex

no changein humans1HR 1.02

1 study
  1. sex was not clearly linked with Parkinson's disease dementia in humans (when accounting for death as competing event) (HR = 1.02, P = 0.770).

    Humanswhen accounting for death as competing event

Associations

12

DCX and MKI67 expression

downin humans1

1 study
  1. Parkinson's disease dementia is associated with DCX and MKI67 expression in humans (Parkinson disease dementia).

    HumansParkinson disease dementiahippocampus

    Brain chemical byproducts linked to neuron formation in humans

    bioRxivPreprint

More on DCX and MKI67 expression

Hearing impairment

upin humans1

1 study
  1. Hearing impairment is linked with a higher risk of Parkinson's disease dementia in humans (insufficient hearing category) (p = .024).

    Humansinsufficient hearing category8.93 yearsn = 158,686

More on Hearing impairment

Smoking

downin humans1HR 0.41

1 study
  1. Smoking is linked with a lower risk of Parkinson's disease dementia in humans (adjusted for age, race, sex, education level, APOE ε4 status, and other VRFs) (HR 0.41, 95% CI 0.18-0.95).

    Humansadjusted for age, race, sex, education level, APOE ε4 status, and other VRFs

More on Smoking

Mortality

upin humans1

1 study
  1. Parkinson's disease dementia is linked with a higher risk of mortality in humans following hip fracture surgery.

    Humansfollowing hip fracture surgeryfirst 4 months post-operativelyn = 111,353

Metabolic syndrome

upin humans1OR 11.3

1 study
  1. Metabolic syndrome is associated with Parkinson's disease dementia in humans (early-stage Parkinson's disease; multivariate logistic regression) (OR 11.3, 95% CI 1.61–79.2).

    Humansearly-stage Parkinson's disease; multivariate logistic regression

More on Metabolic syndrome

CETP activity

downin humans1OR 0.26

1 study
  1. CETP activity is linked with a lower risk of Parkinson's disease dementia in humans (genetically predicted lower concentration) (OR 0.26, 95% CI 0.14–0.48).

    Humansgenetically predicted lower concentration

More on CETP activity

White matter hyperintensities

upin silico1OR 2.035

1 study
  1. White matter hyperintensities raise the risk of Parkinson's disease dementia in silico (OR 2.035, 95% CI 1.105 to 3.745).

    In silico

More on White matter hyperintensities

Subjective olfactory impairment

upin humans1OR 7.44

1 study
  1. Subjective olfactory impairment predicts Parkinson's disease dementia in humans (Cognitively unimpaired at baseline) (OR 7.440).

    HumansCognitively unimpaired at baseline2 years

More on Subjective olfactory impairment

Parkinson's disease severity

upin humans1HR 1.46

1 study
  1. Parkinson's disease severity is linked with a higher risk of Parkinson's disease dementia in humans (HY 3-5 vs. 0-2.5 in competing-risk model) (HR = 1.46, P = 0.011).

    HumansHY 3-5 vs. 0-2.5 in competing-risk modelfemales

Age

upin humans1HR 1.05

1 study
  1. age is linked with a higher risk of Parkinson's disease dementia in humans (competing-risk model) (HR = 1.05, P < 0.001).

    Humanscompeting-risk modelfemales

All 12

Trial sponsors

Funding

3 grants since 2018

National Institute of Neurological Disorders and Stroke$985KUKRI | Medical Research Council£1.8M

Contains public sector information licensed under the Open Government Licence v3.0.

Latest

Dec 2025: 2Jan 2026: 2Feb 2026: 2Mar 2026: 3Apr 2026: 7May 2026: 0Jun 2026: 3Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 2Nov 2026: 223 papers in 12 months
bioRxiv

Brain chemical byproducts linked to neuron formation in humans

A postmortem observational study of young and aged individuals and people with Parkinson disease dementia linked chemical byproducts to gene activity involved in neuron…A postmortem observational study of young and aged individuals and people with Parkinson disease dementia linked chemical byproducts to gene activity involved in neuron formation.

Preprint: cross-sectional studyMechanisms
Journal of Alzheimer's Disease Reports

Statins cut Alzheimer's risk but raise other dementia risks

A Mendelian randomization analysis found total cholesterol mediated 93.91% of statins' effect on overall dementia and 84.37% on dementia in Alzheimer's disease.A Mendelian randomization analysis found total cholesterol mediated 93.91% of statins' effect on overall dementia and 84.37% on dementia in Alzheimer's disease.

Mendelian randomization in peopleStatins

See all 78 papers on Parkinson's disease dementia